{"id":146680,"date":"2026-04-24T13:37:55","date_gmt":"2026-04-24T17:37:55","guid":{"rendered":"https:\/\/medcitynews.com\/?p=146680"},"modified":"2026-04-28T13:22:31","modified_gmt":"2026-04-28T17:22:31","slug":"imaging-glp-1-weight-loss","status":"publish","type":"post","link":"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/","title":{"rendered":"Beyond the Scale: How Imaging Can Help Determine GLP-1 Efficacy"},"content":{"rendered":"\n

The GLP-1 craze is undeniable, with advertising for the injectables flooding our screens and public spaces, restaurants offering GLP-1-friendly menus, and providers restructuring care models around their use.<\/p>\n\n\n\n

About 12%<\/a> of U.S. adults are now estimated to be taking GLP-1 medications since they burst onto the scene a few years ago, marking one of the fastest drug adoption curves in modern medicine. But as this use accelerates, a question is emerging in clinical circles: are these therapies being measured in the right way? <\/p>\n\n\n\n

For many patients using these drugs, success is still defined by the number on the scale. But some healthcare experts say this is an imperfect proxy that can miss crucial changes in fat mass and muscle preservation.<\/p>\n\n\n\n

That\u2019s why telehealth clinic Hone Health<\/a> teamed up with BodySpec<\/a>, a startup that provides imaging for body fat & muscle analysis. Under their partnership<\/a>, which launched this month, Hone patients taking GLP-1s will get access to DEXA (dual-energy X-ray absorptiometry) body composition scans as part of their care.<\/p>\n\n\n\n

The goal is to give more people access to clinical-grade body composition data, said BodySpec CEO Elaine Shi. <\/p>\n\n\n\n

\u201cIn a world where virtual care has made bloodwork, coaching and prescriptions much more accessible, people are still often judging progress on a consumer scale at home \u2014 and that is a very blunt instrument. It can tell you that your weight changed, but not whether you lost fat, lost muscle or changed something important about your health,\u201d she explained.<\/p>\n\n\n\n

In her view, one of the biggest problems in healthcare is that providers often rely on incomplete signals. <\/p>\n\n\n\n

A patient might see their weight drop and assume everything is on track, but weight alone doesn\u2019t tell whether that loss is coming from fat or from lean muscle mass. A body composition scan makes that visible, which means the goal can become much more specific \u2014 not just losing weight, but losing fat while preserving muscle, Shi said.<\/p>\n\n\n\n

The scan allows the provider to tailor the plan accordingly, whether that means a greater focus on protein, adding resistance training or other strategies for sustainable metabolic health.<\/p>\n\n\n\n

\u201cBetter data helps patients and clinicians move from guessing based on proxies to making decisions based on what is actually happening in the body,\u201d Shi declared.<\/p>\n\n\n\n

Patients can purchase their BodySpec scan directly in Hone\u2019s app. They can undergo their scans at one of BodySpec\u2019s locations, which span 12 metro areas across the U.S., including Los Angeles, Chicago, Dallas, Boston and Seattle. The company also has a fleet of 22 vans that serve as mobile DEXA scan clinics.<\/p>\n\n\n\n

As GLP-1 use continues to scale, Shi believes partnerships like this reflect a shift toward measuring outcomes in terms of body composition rather than weight alone. And for many patients, that shift could determine whether these drugs deliver on their long-term promise.<\/p>\n\n\n\n

Photo: THOM LEACH \/ SCIENCE PHOTO LIBRARY, Getty Images<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"

Telehealth clinic Hone Health partnered with imaging company BodySpec to give its patients access to DEXA body composition scans. The partnership seeks to help providers and patients on GLP-1s distinguish fat loss from muscle loss and better evaluate how these drugs are affecting the body.<\/p>\n","protected":false},"author":31620,"featured_media":146681,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"om_disable_all_campaigns":false,"featured_image_focal_point":[],"homepage_placement":"top","homepage_placements":{"top":true,"featured":true,"sidebar":false},"homepage_alternative_layout":false,"featured_categories":[60,51,117,51659],"hide_from_feed":false,"footnotes":""},"categories":[51,117,51659,60],"tags":[53584,53585,48962,52344,9804,53586,12867],"class_list":["post-146680","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medical-devices-and-diagnostics","category-health-tech","category-providers","category-startup-channel","tag-bodyspec","tag-dexa-scan","tag-glp-1","tag-hone-health","tag-imaging","tag-muscle-loss","tag-weight-loss"],"acf":[],"yoast_head":"\nBeyond the Scale: How Imaging Can Help Determine GLP-1 Efficacy - MedCity News<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Beyond the Scale: How Imaging Can Help Determine GLP-1 Efficacy - MedCity News\" \/>\n<meta property=\"og:description\" content=\"Telehealth clinic Hone Health partnered with imaging company BodySpec to give its patients access to DEXA body composition scans. The partnership seeks to help providers and patients on GLP-1s distinguish fat loss from muscle loss and better evaluate how these drugs are affecting the body.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/\" \/>\n<meta property=\"og:site_name\" content=\"MedCity News\" \/>\n<meta property=\"article:published_time\" content=\"2026-04-24T17:37:55+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-04-28T17:22:31+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/medcitynews.com\/wp-content\/uploads\/sites\/7\/2026\/04\/glp-1.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"788\" \/>\n\t<meta property=\"og:image:height\" content=\"443\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Katie Adams\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Katie Adams\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/\"},\"author\":{\"name\":\"Katie Adams\",\"@id\":\"https:\/\/medcitynews.com\/#\/schema\/person\/91c47b5afe1058bd74c8125a1b9248ec\"},\"headline\":\"Beyond the Scale: How Imaging Can Help Determine GLP-1 Efficacy\",\"datePublished\":\"2026-04-24T17:37:55+00:00\",\"dateModified\":\"2026-04-28T17:22:31+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/\"},\"wordCount\":495,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/medcitynews.com\/wp-content\/uploads\/sites\/7\/2026\/04\/glp-1.jpg\",\"keywords\":[\"BodySpec\",\"dexa scan\",\"GLP-1\",\"Hone Health\",\"imaging\",\"muscle loss\",\"weight loss\"],\"articleSection\":[\"Devices & Diagnostics\",\"Health Tech\",\"Providers\",\"Startups\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/\",\"url\":\"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/\",\"name\":\"Beyond the Scale: How Imaging Can Help Determine GLP-1 Efficacy - MedCity News\",\"isPartOf\":{\"@id\":\"https:\/\/medcitynews.com\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/medcitynews.com\/wp-content\/uploads\/sites\/7\/2026\/04\/glp-1.jpg\",\"datePublished\":\"2026-04-24T17:37:55+00:00\",\"dateModified\":\"2026-04-28T17:22:31+00:00\",\"author\":{\"@id\":\"https:\/\/medcitynews.com\/#\/schema\/person\/91c47b5afe1058bd74c8125a1b9248ec\"},\"breadcrumb\":{\"@id\":\"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/#primaryimage\",\"url\":\"https:\/\/medcitynews.com\/wp-content\/uploads\/sites\/7\/2026\/04\/glp-1.jpg\",\"contentUrl\":\"https:\/\/medcitynews.com\/wp-content\/uploads\/sites\/7\/2026\/04\/glp-1.jpg\",\"width\":788,\"height\":443,\"caption\":\"Semaglutide weight loss drug, conceptual illustration. Marketed as Ozempic, semaglutide is a glucagon-like peptide-1 (GLP-1) analogue that is used to treat diabetes and for weight management. It increases the production of insulin, the hormone that lowers blood sugar levels, while also suppressing secretion of glucagon, the hormone that raises blood sugar levels. It also reduces hunger and slows gastric emptying\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/medcitynews.com\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Beyond the Scale: How Imaging Can Help Determine GLP-1 Efficacy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/medcitynews.com\/#website\",\"url\":\"https:\/\/medcitynews.com\/\",\"name\":\"MedCity News\",\"description\":\"Healthcare technology news, life science current events\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/medcitynews.com\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/medcitynews.com\/#\/schema\/person\/91c47b5afe1058bd74c8125a1b9248ec\",\"name\":\"Katie Adams\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/medcitynews.com\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/medcitynews.com\/wp-content\/uploads\/sites\/7\/2023\/05\/cropped-MedCityFinals-45-4-scaled-1-96x96.jpg\",\"contentUrl\":\"https:\/\/medcitynews.com\/wp-content\/uploads\/sites\/7\/2023\/05\/cropped-MedCityFinals-45-4-scaled-1-96x96.jpg\",\"caption\":\"Katie Adams\"},\"description\":\"Katie Adams is a senior reporter for MedCity News covering providers and healthcare technology. Previously, she worked as a healthcare technology editor at Becker\u2019s Hospital Review. Her journalism degree is from DePaul University in Chicago, where she is still based. LinkedIn: https:\/\/www.linkedin.com\/in\/katie-adams-450775141\/\",\"sameAs\":[\"https:\/\/www.linkedin.com\/in\/katie-adams-450775141\/\"],\"url\":\"https:\/\/medcitynews.com\/author\/kadams\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Beyond the Scale: How Imaging Can Help Determine GLP-1 Efficacy - MedCity News","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/","og_locale":"en_US","og_type":"article","og_title":"Beyond the Scale: How Imaging Can Help Determine GLP-1 Efficacy - MedCity News","og_description":"Telehealth clinic Hone Health partnered with imaging company BodySpec to give its patients access to DEXA body composition scans. The partnership seeks to help providers and patients on GLP-1s distinguish fat loss from muscle loss and better evaluate how these drugs are affecting the body.","og_url":"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/","og_site_name":"MedCity News","article_published_time":"2026-04-24T17:37:55+00:00","article_modified_time":"2026-04-28T17:22:31+00:00","og_image":[{"width":788,"height":443,"url":"https:\/\/medcitynews.com\/wp-content\/uploads\/sites\/7\/2026\/04\/glp-1.jpg","type":"image\/jpeg"}],"author":"Katie Adams","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Katie Adams","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/#article","isPartOf":{"@id":"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/"},"author":{"name":"Katie Adams","@id":"https:\/\/medcitynews.com\/#\/schema\/person\/91c47b5afe1058bd74c8125a1b9248ec"},"headline":"Beyond the Scale: How Imaging Can Help Determine GLP-1 Efficacy","datePublished":"2026-04-24T17:37:55+00:00","dateModified":"2026-04-28T17:22:31+00:00","mainEntityOfPage":{"@id":"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/"},"wordCount":495,"commentCount":0,"image":{"@id":"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/#primaryimage"},"thumbnailUrl":"https:\/\/medcitynews.com\/wp-content\/uploads\/sites\/7\/2026\/04\/glp-1.jpg","keywords":["BodySpec","dexa scan","GLP-1","Hone Health","imaging","muscle loss","weight loss"],"articleSection":["Devices & Diagnostics","Health Tech","Providers","Startups"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/","url":"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/","name":"Beyond the Scale: How Imaging Can Help Determine GLP-1 Efficacy - MedCity News","isPartOf":{"@id":"https:\/\/medcitynews.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/#primaryimage"},"image":{"@id":"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/#primaryimage"},"thumbnailUrl":"https:\/\/medcitynews.com\/wp-content\/uploads\/sites\/7\/2026\/04\/glp-1.jpg","datePublished":"2026-04-24T17:37:55+00:00","dateModified":"2026-04-28T17:22:31+00:00","author":{"@id":"https:\/\/medcitynews.com\/#\/schema\/person\/91c47b5afe1058bd74c8125a1b9248ec"},"breadcrumb":{"@id":"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/#primaryimage","url":"https:\/\/medcitynews.com\/wp-content\/uploads\/sites\/7\/2026\/04\/glp-1.jpg","contentUrl":"https:\/\/medcitynews.com\/wp-content\/uploads\/sites\/7\/2026\/04\/glp-1.jpg","width":788,"height":443,"caption":"Semaglutide weight loss drug, conceptual illustration. Marketed as Ozempic, semaglutide is a glucagon-like peptide-1 (GLP-1) analogue that is used to treat diabetes and for weight management. It increases the production of insulin, the hormone that lowers blood sugar levels, while also suppressing secretion of glucagon, the hormone that raises blood sugar levels. It also reduces hunger and slows gastric emptying"},{"@type":"BreadcrumbList","@id":"https:\/\/medcitynews.com\/2026\/04\/imaging-glp-1-weight-loss\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/medcitynews.com\/"},{"@type":"ListItem","position":2,"name":"Beyond the Scale: How Imaging Can Help Determine GLP-1 Efficacy"}]},{"@type":"WebSite","@id":"https:\/\/medcitynews.com\/#website","url":"https:\/\/medcitynews.com\/","name":"MedCity News","description":"Healthcare technology news, life science current events","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/medcitynews.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/medcitynews.com\/#\/schema\/person\/91c47b5afe1058bd74c8125a1b9248ec","name":"Katie Adams","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/medcitynews.com\/#\/schema\/person\/image\/","url":"https:\/\/medcitynews.com\/wp-content\/uploads\/sites\/7\/2023\/05\/cropped-MedCityFinals-45-4-scaled-1-96x96.jpg","contentUrl":"https:\/\/medcitynews.com\/wp-content\/uploads\/sites\/7\/2023\/05\/cropped-MedCityFinals-45-4-scaled-1-96x96.jpg","caption":"Katie Adams"},"description":"Katie Adams is a senior reporter for MedCity News covering providers and healthcare technology. Previously, she worked as a healthcare technology editor at Becker\u2019s Hospital Review. Her journalism degree is from DePaul University in Chicago, where she is still based. LinkedIn: https:\/\/www.linkedin.com\/in\/katie-adams-450775141\/","sameAs":["https:\/\/www.linkedin.com\/in\/katie-adams-450775141\/"],"url":"https:\/\/medcitynews.com\/author\/kadams\/"}]}},"_links":{"self":[{"href":"https:\/\/medcitynews.com\/wp-json\/wp\/v2\/posts\/146680","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medcitynews.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medcitynews.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medcitynews.com\/wp-json\/wp\/v2\/users\/31620"}],"replies":[{"embeddable":true,"href":"https:\/\/medcitynews.com\/wp-json\/wp\/v2\/comments?post=146680"}],"version-history":[{"count":3,"href":"https:\/\/medcitynews.com\/wp-json\/wp\/v2\/posts\/146680\/revisions"}],"predecessor-version":[{"id":146777,"href":"https:\/\/medcitynews.com\/wp-json\/wp\/v2\/posts\/146680\/revisions\/146777"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medcitynews.com\/wp-json\/wp\/v2\/media\/146681"}],"wp:attachment":[{"href":"https:\/\/medcitynews.com\/wp-json\/wp\/v2\/media?parent=146680"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medcitynews.com\/wp-json\/wp\/v2\/categories?post=146680"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medcitynews.com\/wp-json\/wp\/v2\/tags?post=146680"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}